Assura PLC (LON:AGR) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $63.22 and traded as low as $70.20. Assura shares last traded at $71.30, with a volume of 2,349,501 shares trading hands.
A number of brokerages recently weighed in on AGR. Liberum Capital restated a “hold” rating on shares of Assura in a research note on Tuesday, July 2nd. Peel Hunt restated a “hold” rating on shares of Assura in a research note on Tuesday, September 17th.
The business has a fifty day moving average of GBX 68.99 and a 200-day moving average of GBX 63.22. The stock has a market capitalization of $1.70 billion and a price-to-earnings ratio of 20.37. The company has a debt-to-equity ratio of 53.61, a current ratio of 0.73 and a quick ratio of 0.39.
The company also recently announced a dividend, which will be paid on Wednesday, October 16th. Investors of record on Thursday, September 12th will be issued a dividend of GBX 0.69 ($0.01) per share. This represents a yield of 0.97%. The ex-dividend date is Thursday, September 12th. Assura’s payout ratio is currently 0.86%.
In related news, insider Orla Ball sold 9,733 shares of Assura stock in a transaction dated Monday, September 9th. The stock was sold at an average price of GBX 71 ($0.93), for a total transaction of £6,910.43 ($9,029.70). Also, insider Jonathan Murphy sold 102,907 shares of Assura stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of GBX 65 ($0.85), for a total value of £66,889.55 ($87,403.04).
About Assura (LON:AGR)
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.
Recommended Story: What is Cost of Debt?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.